CXCL2 and cancer: Unlike S100A8/A9, the abundance of CXCL1, CXCL2, and CXCL5 chemokines in scaffolds neither increased following the infiltration of cancer-induced neutrophils in MNs after tumor inoculation nor decreased after systemic depletion of neutrophils in tumor-bearing mice (Fig. 5k).